Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SciSparc Ltd. ( (SPRC) ) just unveiled an update.
In August 2025, SciSparc Ltd. issued 999,528 ordinary shares to investors who converted their debentures into equity, following agreements made in February 2025. This conversion leaves $175,000 of the debentures outstanding, impacting the company’s share structure and potentially its market positioning.
More about SciSparc Ltd.
SciSparc Ltd. operates in the biotechnology industry, focusing on the development of therapies for central nervous system disorders. The company is known for its innovative approach to treating conditions such as Alzheimer’s disease and Tourette syndrome.
Average Trading Volume: 305,480
Technical Sentiment Signal: Sell
Current Market Cap: $1.62M
For detailed information about SPRC stock, go to TipRanks’ Stock Analysis page.